29 Aug 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Dr Joseph Rogers has joined SRI's biosciences division as executive director of a new health sciences section that brings together researchers from SRI's Center for Health Sciences, led by Dr Gary Swan, with SRI's Center for Neuroscience and Metabolic Diseases, led by Dr Thomas Kilduff.
The combination offers SRI clients and partners more integrated bench-to-bedside capabilities in areas such as addiction, alcoholism, Alzheimer's and Parkinson's diseases, Down syndrome, sleep disorders, and more. SRI's Biosciences division carries out basic research, drug discovery, and drug development, and provides contract (CRO) services. Apart from the head office in the US, it has an office in Tokyo, Japan, and in Greenland and Dubai.
"We are fortunate to have Joe Rogers leading the new Health Sciences Section at SRI," said Dr Walter H. Moos, vice president, Biosciences Division at SRI. "Joe is an outstanding, award-winning researcher whose focus on age-related neurologic diseases will be a valuable asset to SRI's expanded health research, drug discovery, and drug development programs."
Dr Rogers is best known for showing that inflammatory responses occur in almost all major age-related brain disorders and cause substantial damage, with his seminal paper in the area receiving nearly 1,200 citations to date. Before joining SRI, Dr Rogers served as founder and president of the Sun Health Research Institute (acquired by Banner Health System). Under his leadership, the institute became internationally recognized for its research on age-related neurological diseases, and is a National Institutes of Health (NIH) funded National Alzheimer's Disease Center.